Registration Dossier
Registration Dossier
Data platform availability banner - registered substances factsheets
Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.
The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 931-801-1 | CAS number: -
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data
![](https://poisoncentres.echa.europa.eu/o/diss-blank-theme/images/factsheets/A-REACH/factsheet/print_toxicological-information.png)
Endpoint summary
Administrative data
Description of key information
RA-S CAS 124-26-5, OECD 423, oral rat: LD50cut off 5000 mg/kg bw (ATC method)
RA-S CAS 112-84-5, OECD 436, inhal. rat: LC50 >2.8 mg/L (ATC method)
RA-S CAS 112-84-5, OECD 402 dermal rat: LD50 >2000 mg/kg bw (limit test)
Key value for chemical safety assessment
Acute toxicity: via oral route
Endpoint conclusion
- Dose descriptor:
- LD50
- Value:
- 5 000 mg/kg bw
Acute toxicity: via inhalation route
Endpoint conclusion
- Dose descriptor:
- LC50
- Value:
- 2 800 mg/m³ air
Acute toxicity: via dermal route
Endpoint conclusion
- Dose descriptor:
- LD50
- Value:
- 2 000 mg/kg bw
Additional information
No test data for oleamide is available for acute toxicity testing. Therefore, read-acrosses from structurally related substances, stearamide (CAS 124-26-5) and erucamide (CAS 112-84-5), are included for regulatory purposes.
Strearamide is the fatty acid amide resulting from amidation of stearic acid, the saturated C18-carbon acid. The only difference to oleic acid is the absence of the C=C double bond at position 9 of the carbon chain. Like oleamide (Cooper, 1995), stearamide will be cleaved by gastrointestinal fluids. Stearic acid can be desaturated to oleic acid within the body (Emken, 1994), and both metabolites will follow the same metabolical pathways (compare toxicokinetics, metabolism and distribution). Like oleic acid, stearic acid is a common part of our daily nutrition (Beare-Rogers, 2001). Furthermore, it is an element of many molecules with endogenous functions.
Erucamide is the fatty acid amide resulting from the amidation of erucic acid. Erucic acid is a mono-unsaturated fatty acid with a carbon chain consisting of 22 carbon atoms with a double bond at position 13 (omega-9) of the carbon chain (cis-docos-13-enoic acid). Comparable to oleamide and stearamide it is not classified in Annex I of Directive 67/548/EEC, and does not have to be self-classified according to the available experimental data. Erucic acid is also present in various oils and fats which are part of our diets (20-40% in oils from mustard seeds and up to 50% in original high erucic rapeseed oil, <2% in low erucic acid rapeseed oil; Beare-Rogers, 2001) and will also be broken down into shorter-chain fatty acids in the process of beta-oxidation. One of the most famoust uses is in Lorenzo's oil, a 4:1 mixture of the triglyceride forms of oleic and erucic acid, i.e. an investigational drug used for the treatment of adrenoleukodystrophy, for which an U.S. Patent was established. Testing of erucamide for acute oral toxicity following OECD guideline 423 as limit test with a starting dose of 2000 mg/kg bw, performed by the same testing facility as for stearamide, revealed comparable results to stearamide: no mortality occurred, no signs of systemic toxicity were observed, and animals showed the expected gains in bodyweight.
Therefore, these substances are considered to have toxicological characteristics comparable to each other and to oleamide. Considering animal welfare reasons, read-across from tests for acute toxicity conducted with stearamide (CAS 124-26-5) and erucamide (CAS 112-84-5) is reasonable and justified.
There is data available from an acute oral toxicity study following OECD Guideline 423 (Acute Toxic Class Method) in form of a limit test with stearamide (Sanders, 2000). A starting dose of 2000 mg/kg bw was subsequently applied to 3 animals of each sex. No mortality occurred either in the females nor in the males, no signs of systemic toxicity were observed, and the animals showed the expected gain in bodyweight during the study. Therefore, according to the scheme outlined in Annex 2d of OECD guideline 423 the LD50 cut-off value for acute oral toxicity was determined to be 5000 mg/kg bw.
The acute inhalation toxicity test was performed according to OECD Guideline 436 (Acute Toxic Class Method) with the maximum attainable aerosol concentration of erucamide still ensuring particles with a respirable MMAD as recommended in the guideline (Pothman, 2010). In the study the animals were nose-only exposed for 4 hours to an aerosol with MMADs ranging from 3.02 to 3.84 µm and a concentration of 2.8 mg/L. No mortality occurred, and the only effects observed during the 14-day observation period were ruffled fur one hour after the end of exposure and slight body weight loss from day 1 to day 2. No effects were observed from day 2 onwards. Therefore, the LC50 was established to be >2.8 mg/L for a 4-hour exposure period. According to OECD Guideline 436, Annex 5d for Acute Inhalation Toxicity testing with a starting concentration of 5 mg/L/4h for dusts and mists, the LC50 cut-off for acute inhalation toxicity can even be defined as "∞", as the starting dose already represented the maximum technically attainable concentration, and under handling conditions no higher concentration of a comparable respirable size will occur.
The acute dermal toxicity study with erucamide, designed as limit test, was performed according to OECD Guideline 402 (Braun, 2010). Five rats per sex were exposed for 24 hours to a dose of 2000 mg/kg bw under semicocclusive conditions. After exposure the treated skin sites were cleaned with lukewarm water and the dermal reactions were assessed. During the 14-day observation period no mortality occurred; no signs of systemic toxicity were observed, and the animals showed the expected gains of body weight. Local observations at the exposure site in form of slight desquamation were made in one male on observation days 7 and 8; no dermal effects were observed in th females. Therefore, the LD50 for acute dermal toxicity was determined to be >2000 mg/kg bw.
Justification for classification or non-classification
Based on the results from structurally related substances, oleamide does not have to be classified for acute toxicity according to the DSD and the criteria of the CLP regulation.
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.
![ECHA](/o/diss-blank-theme/images/factsheets/A-REACH/factsheet/echa_logo.png)